Literature DB >> 25896756

Patient-centric HTA: different strokes for different folks.

Axel C Mühlbacher1.   

Abstract

Patient centricity will initiate a change in healthcare decision-making paradigms. Patient-centered outcomes are a part of the solution to the challenges posed by complex decision problems due to multiple clinical and non-clinical outcomes. Multiple decision criteria require that clinical and regulatory decisions be based on the implicit value judgments of experts. Experts are under continuous pressure to ensure decisions are aligned with patient needs and result in positive performance. To fulfill this role and guarantee efficient decisions, experts must be fully informed about patient preferences; however, this assumption might not necessarily reflect reality. Health technology assessment focuses on the measurement of clinical effects, rather than the assessment of the impact of different outcomes on users' perceived value. Further evidence is needed to ensure that expert judgments are congruent with patient preferences. Therefore, patient preferences can be a valuable source of information to inform clinical and regulatory decision-makers.

Entities:  

Keywords:  health technology assessment; multi-criteria decision-making; patient centricity; patient heterogeneity; patient preferences; patient segmentation; patient-centered health care

Mesh:

Year:  2015        PMID: 25896756     DOI: 10.1586/14737167.2015.1038245

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  8 in total

1.  Incorporating Quantitative Patient Preference Data into Healthcare Decision Making Processes: Is HTA Falling Behind?

Authors:  David John Mott
Journal:  Patient       Date:  2018-06       Impact factor: 3.883

2.  The development of PubMed search strategies for patient preferences for treatment outcomes.

Authors:  Ralph van Hoorn; Wietske Kievit; Andrew Booth; Kati Mozygemba; Kristin Bakke Lysdahl; Pietro Refolo; Dario Sacchini; Ansgar Gerhardus; Gert Jan van der Wilt; Marcia Tummers
Journal:  BMC Med Res Methodol       Date:  2016-07-29       Impact factor: 4.615

3.  Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA.

Authors:  Rosanne Janssens; Selena Russo; Eline van Overbeeke; Chiara Whichello; Sarah Harding; Jürgen Kübler; Juhaeri Juhaeri; Karin Schölin Bywall; Alina Comanescu; Axel Hueber; Matthias Englbrecht; Nikoletta Nikolenko; Gabriella Pravettoni; Steven Simoens; Hilde Stevens; Richard Hermann; Bennett Levitan; Irina Cleemput; Esther de Bekker-Grob; Jorien Veldwijk; Isabelle Huys
Journal:  Patient       Date:  2019-10       Impact factor: 3.883

4.  Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries.

Authors:  Maria Dimitrova; Ivett Jakab; Zornitsa Mitkova; Maria Kamusheva; Konstantin Tachkov; Bertalan Nemeth; Antal Zemplenyi; Dalia Dawoud; Diana M J Delnoij; François Houýez; Zoltan Kalo
Journal:  Front Public Health       Date:  2022-07-28

5.  Defining patient centricity with patients for patients and caregivers: a collaborative endeavour.

Authors:  Guy Yeoman; Patricia Furlong; Michael Seres; Helena Binder; Helena Chung; Vincenzo Garzya; Rachel Rm Jones
Journal:  BMJ Innov       Date:  2017-03-24

6.  Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review.

Authors:  Rosanne Janssens; Isabelle Huys; Eline van Overbeeke; Chiara Whichello; Sarah Harding; Jürgen Kübler; Juhaeri Juhaeri; Antonio Ciaglia; Steven Simoens; Hilde Stevens; Meredith Smith; Bennett Levitan; Irina Cleemput; Esther de Bekker-Grob; Jorien Veldwijk
Journal:  BMC Med Inform Decis Mak       Date:  2019-10-04       Impact factor: 2.796

7.  Value in Hepatitis C Virus Treatment: A Patient-Centered Cost-Effectiveness Analysis.

Authors:  T Joseph Mattingly; Julia F Slejko; Eberechukwu Onukwugha; Eleanor M Perfetto; Shyamasundaran Kottilil; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2020-02       Impact factor: 4.981

Review 8.  Patient and Public Preferences for Coordinated Care in Switzerland: Development of a Discrete Choice Experiment.

Authors:  Anna Nicolet; Clémence Perraudin; Joël Wagner; Ingrid Gilles; Nicolas Krucien; Isabelle Peytremann-Bridevaux; Joachim Marti
Journal:  Patient       Date:  2022-01-24       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.